Form 10-Q Kiniksa Pharmaceuticals For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
Kiniksa (KNSA) PT Raised to $35 at Evercore ISI
October 29, 2024 4:23 PM EDTEvercore ISI analyst Liisa Bayko raised the price target on Kiniksa (NASDAQ: KNSA) to $35.00 (from $30.00) while maintaining a Outperform rating.
The analyst comments "KNSA has a solid Q with $112.2M Arcalyst sales slightly beating consensus of $111.5M. KNSA raised... More



